 "The company already enjoys a 67-68 per cent share of the respiratory drugs market in India and has potential for a 14-15 per cent growth")
As many as 2,783 samples or 3.36 per cent of the total 82,599 samples tested by drug controllers of various states and Union Territories in 2017-18 were declared substandard, Parliament was told on Tuesday. Of the total, 236 samples or 0.28 per cent were declared spurious or adulterated, Junior minister Mansukh L Mandaviya told the Lok Sabha.He said 2,783 samples of drugs were “declared not of standard quality” out of 82,599 samples tested, which is 3.36 per cent of the total.
In 2016-17, the total number of drugs samples tested was 76,721, of which 2,780 were declared not of
In 2016-17, the total number of drugs samples tested was 76,721, of which 2,780 were declared not of
